Back HIV Prevention HIV Vaccines

HIV Vaccines

Research Offers Clues to Modest Protection in Thai HIV Vaccine Trial

Researchers have learned more about how an experimental vaccine provides partial protection against HIV infection, according to a report in the April 5, 2012, issue of the New England Journal of Medicine.alt

Read more:

CROI 2012: Broadly Neutralizing Antibodies Can Help Fight HIV [VIDEO]

Recent discoveries about broadly neutralizing antibodies are helping advance the field of HIV vaccine development, according to Dennis Burton from the Scripps Research Institute and the Ragon Institute of MGH, MIT, and Harvard, who presented the annual Bernard Fields Lecture on Monday at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.alt

Read more:

Vacc-4x Therapeutic HIV Vaccine Linked to Lower Viral Load in Phase IIb Study

An experimental therapeutic vaccine reduced HIV viral load among patients who remained off antiretroviral therapy (ART) for up to 24 weeks, suggesting it effectively stimulates the immune system's response to the virus, according to study finding released last week by Bionor Pharma, a Norwegian biotech company.alt

Read more:

CROI 2012: Conference Overview Highlights Biomedical HIV Prevention

HIV prevention was the key theme at Monday's opening press overview of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), taking place this week in Seattle.alt

Read more:

Experimental Vaccine Offers Partial Protection against HIV-Related Virus in Monkeys

An investigational adenovirus prime-poxvirus booster vaccine regimen reduced the likelihood of infection in rhesus monkeys exposed to simian immunodeficiency virus (SIV), a monkey virus similar to HIV, researchers reported in the January 4, 2011, advance online edition of Nature. The vaccine reduced infection risk by about 80% compared with placebo, and monkeys that did become infected had lower viral loads.alt

Read more: